Global Influenza Surveillance and Response System

Last updated

The Global Influenza Surveillance and Response System (GISRS) is a global network of laboratories that has for purpose to monitor the spread of influenza with the aim to provide the World Health Organization with influenza control information. [1] It was established in 1952 to conduct global influenza surveillance. [2] GISRS is coordinated by WHO and endorsed by national governments. More than two million respiratory specimens are tested by GISRS annually to monitor the spread and evolution of influenza viruses through a network of about 150 laboratories in 114 countries representing 91% of the world's population. [3] GISRS operates FluNet, an online tool used for virological surveillance of influenza. [1]

Contents

History

In 1947, the WHO Interim Committee of the United Nations agreed to begin a Global Influenza Programme (GIP) for the study and control of influenza. A major outbreak of influenza in Europe was an immediate concern, as well as the identification of appropriate viruses for a vaccine against the virus strains which might be circulating. The establishment of regional influenza centers began in 1948. Five years after the creation of GIP, the Global Influenza Surveillance Network (GISN) was established in response to a need for an influenza surveillance system to inform the methods for disease prevention and control. GISN would later be renamed Global Influenza Surveillance and Response System (GISRS), [4] evolving as an integrated scientific and technical global collaboration to fulfil the objectives and activities of GIP. [5] GISRS gained momentum between the 1957 and 1968 pandemics. The growing network of national influenza centers focused on understanding disease activity and characteristics of influenza viruses globally. Through these efforts, the realization that the viruses were not only present in tropical countries but might circulate for much of the year was confirmed. [6]

Composition

As of 2015, GISRS comprised 142 national influenza centers in 115 countries, [7] 6 WHO collaborating centers, 4 WHO essential regulatory laboratories, and 13 WHO H5 reference laboratories. [8]

Efficacy

GISRS is considered an "effective early warning system" for changes in influenza viruses circulating in the global population, which helps mitigate the consequences of a pandemic and maintain the efficacy of seasonal influenza vaccines. [9]

See also

Related Research Articles

<span class="mw-page-title-main">Pandemic</span> Widespread, often global, epidemic of severe infectious disease

A pandemic is an epidemic of an infectious disease that has spread across a large region, for instance multiple continents or worldwide, affecting a substantial number of individuals. Widespread endemic diseases with a stable number of infected individuals such as recurrences of seasonal influenza are generally excluded as they occur simultaneously in large regions of the globe rather than being spread worldwide.

<span class="mw-page-title-main">Avian influenza</span> Influenza caused by viruses adapted to birds

Avian influenza, also known as avian flu, is a bird flu caused by the influenza A virus, which can infect people. It is similar to other types of animal flu in that it is caused by a virus strain that has adapted to a specific host. The type with the greatest risk is highly pathogenic avian influenza (HPAI).

<span class="mw-page-title-main">Oseltamivir</span> Antiviral medication used against influenza A and influenza B

Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. They recommend it to prevent infection in those at high risk, but not the general population. The Centers for Disease Control and Prevention (CDC) recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. It is taken by mouth, either as a pill or liquid.

<span class="mw-page-title-main">Influenza vaccine</span> Vaccine against influenza

Influenza vaccines, also known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The United States Centers for Disease Control and Prevention (CDC) estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. Immunized workers who do catch the flu return to work half a day sooner on average. Vaccine effectiveness in those over 65 years old remains uncertain due to a lack of high-quality research.

The Hong Kong flu, also known as the 1968 flu pandemic, was a flu pandemic whose outbreak in 1968 and 1969 killed between one and four million people globally. It is among the deadliest pandemics in history, and was caused by an H3N2 strain of the influenza A virus. The virus was descended from H2N2 through antigenic shift, a genetic process in which genes from multiple subtypes are reassorted to form a new virus.

<span class="mw-page-title-main">Swine influenza</span> Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

<span class="mw-page-title-main">Flu season</span> Recurring periods of influenza

Flu season is an annually recurring time period characterized by the prevalence of an outbreak of influenza (flu). The season occurs during the cold half of the year in each hemisphere. It takes approximately two days to show symptoms. Influenza activity can sometimes be predicted and even tracked geographically. While the beginning of major flu activity in each season varies by location, in any specific location these minor epidemics usually take about three weeks to reach its pinnacle, and another three weeks to significantly diminish.

<span class="mw-page-title-main">Influenza A virus subtype H1N1</span> Subtype of Influenza A virus

In virology, influenza A virus subtype H1N1 (A/H1N1) is a subtype of influenza A virus. Major outbreaks of H1N1 strains in humans include the 1918 Spanish flu pandemic, the 1977 Russian flu pandemic and the 2009 swine flu pandemic. It is an orthomyxovirus that contains the glycoproteins hemagglutinin (H) and neuraminidase (N), antigens whose subtypes are used to classify the strains of the virus as H1N1, H1N2 etc. Hemagglutinin causes red blood cells to clump together and binds the virus to the infected cell. Neuraminidase is a type of glycoside hydrolase enzyme which helps to move the virus particles through the infected cell and assist in budding from the host cells.

<span class="mw-page-title-main">Influenza pandemic</span> Pandemic involving influenza

An influenza pandemic is an epidemic of an influenza virus that spreads across a large region and infects a large proportion of the population. There have been six major influenza epidemics in the last 140 years, with the 1918 flu pandemic being the most severe; this is estimated to have been responsible for the deaths of 50–100 million people. The most recent, the 2009 swine flu pandemic, resulted in under 300,000 deaths and is considered relatively mild. These pandemics occur irregularly.

<span class="mw-page-title-main">Influenza</span> Infectious disease, often just "the flu"

Influenza, commonly known as "the flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">Influenza-like illness</span> Medical diagnosis

Influenza-like illness (ILI), also known as flu-like syndrome or flu-like symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms. These include fever, shivering, chills, malaise, dry cough, loss of appetite, body aches, and nausea, sneezing typically in connection with a sudden onset of illness. In most cases, the symptoms are caused by cytokines released by immune system activation, and are thus relatively non-specific.

<span class="mw-page-title-main">2009 swine flu pandemic</span> 2009–2010 pandemic of swine influenza caused by H1N1 influenza virus

The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, is the third recent flu pandemic involving the H1N1 virus. The first two cases were discovered independently in the United States in April 2009. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".

<span class="mw-page-title-main">Pandemic H1N1/09 virus</span> Virus responsible for the 2009 swine flu pandemic

The pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media. For other names, see the Nomenclature section below.

<span class="mw-page-title-main">Influenza A virus subtype H7N9</span> Subtype of the influenza A virus

Influenza A virus subtype H7N9 (A/H7N9) is a bird flu strain of the species Influenza virus A. Avian influenza A H7 viruses normally circulate amongst avian populations with some variants known to occasionally infect humans. An H7N9 virus was first reported to have infected humans in March 2013, in China. Cases continued to be reported throughout April and then dropped to only a few cases during the summer months. At the closing of the year, 144 cases had been reported of which 46 had died. It is known that influenza tends to strike during the winter months, and the second wave, which began in October, was fanned by a surge in poultry production timed for Lunar New Year feasts that began at the end of January. January 2014 brought a spike in reports of illness with 96 confirmed reports of disease and 19 deaths. As of April 11, 2014, the outbreak's overall total was 419, including 7 in Hong Kong, and the unofficial number of deaths was 127.

Pandemic prevention is the organization and management of preventive measures against pandemics. Those include measures to reduce causes of new infectious diseases and measures to prevent outbreaks and epidemics from becoming pandemics.

<span class="mw-page-title-main">Arnold Monto</span> American physician and epidemiologist

Arnold Monto is an American physician and epidemiologist. At the University of Michigan School of Public Health, Monto is the Thomas Francis Jr. Collegiate Professor of Public Health, professor of epidemiology, and professor of global public health. His research focuses on the occurrence, prevention, and treatment of infectious diseases in industrialized and developing countries' populations.

<span class="mw-page-title-main">1957–1958 influenza pandemic</span> Pandemic of influenza virus (H2N2)

The 1957–1958 Asian flu pandemic was a global pandemic of influenza A virus subtype H2N2 that originated in Guizhou in Southern China. The number of excess deaths caused by the pandemic is estimated to be 1–4 million around the world, making it one of the deadliest pandemics in history. A decade later, a reassorted viral strain H3N2 further caused the Hong Kong flu pandemic (1968–1969).

The Global Influenza Programme (GIP) is a program launched in 1947 by the World Health Organization with the purpose to provide member states with guidance, support and coordination of activities in order to make their health systems better prepared against seasonal, zoonotic and pandemic influenza threats to populations and individuals. GIP was initiated as one of WHO's initial programs.

Viral interference, also known as superinfection resistance, is the inhibition of viral reproduction caused by previous exposure of cells to another virus. The exact mechanism for viral interference is unknown. Factors that have been implicated are the generation of interferons by infected cells, and the occupation or down-modulation of cellular receptors.

Type A influenza vaccine is for the prevention of infection of influenza A virus and also the influenza-related complications. Different monovalent type A influenza vaccines have been developed for different subtypes of influenza A virus including H1N1 and H5N1. Both intramuscular injection or intranasal spray are available on market. Unlike the seasonal influenza vaccines which are used annually, they are usually used during the outbreak of certain strand of subtypes of influenza A. Common adverse effects includes injection site reaction and local tenderness. Incidences of headache and myalgia were also reported with H1N1 whereas cases of fever has also been demonstrated with H5N1 vaccines. It is stated that immunosuppressant therapies would reduce the therapeutic effects of vaccines and that people with egg allergy should go for the egg-free preparations.

References

  1. 1 2 Lee, Kelley; Fang, Jennifer (2013). Historical Dictionary of the World Health Organization. ISBN   9780810878587.
  2. ↑ "Global Influenza Surveillance and Response System (GISRS)". who.int. Archived from the original on October 3, 2011. Retrieved 25 May 2020.
  3. ↑ Broor, Shobha; Campbell, Harry; Hirve, Siddhivinayak; Hague, Siri; Jackson, Sandra; Moen, Ann; Nair, Harish; Palekar, Rakhee; Rajatonirina, Soatiana; Smith, Peter G; Venter, Marietjie; Wairagkar, Niteen; Zambon, Maria; Ziegler, Thedi; Zhang, Wenqing (2019). "Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges". Influenza and Other Respiratory Viruses. 14 (6): 622–629. doi: 10.1111/irv.12672 . PMC   7578328 . PMID   31444997. CC BY icon-80x15.png  This article incorporates text available under the CC BY 4.0 license.
  4. ↑ Monto, Arnold S. (2018). "Reflections on The Global Influenza Surveillance and Response System (GISRS) at 65 Years: An Expanding Framework for Influenza Detection, Prevention and Control". Influenza and Other Respiratory Viruses. 12 (1): 10–12. doi: 10.1111/irv.12511 . PMC   5818347 . PMID   29460424. CC BY icon-80x15.png  This article incorporates text available under the CC BY 4.0 license.
  5. ↑ Hay, Alan J; McCauley, John W (2018). "The WHO global influenza surveillance and response system (GISRS)—A future perspective". Influenza and Other Respiratory Viruses. 12 (5): 551–557. doi:10.1111/irv.12565. PMC   6086842 . PMID   29722140.
  6. ↑ Monto, Arnold S. (2018). "Reflections on The Global Influenza Surveillance and Response System (GISRS) at 65 Years: An Expanding Framework for Influenza Detection, Prevention and Control". Influenza and Other Respiratory Viruses. 12 (1): 10–12. doi: 10.1111/irv.12511 . PMC   5818347 . PMID   29460424. CC BY icon-80x15.png  This article incorporates text available under the CC BY 4.0 license.
  7. ↑ "WHO Global Influenza Surveillance and Response System (GISRS) Surveillance and Vaccine Development". influenzacentre.org. Archived from the original on 4 June 2020. Retrieved 25 May 2020.
  8. ↑ "Global Influenza Surveillance and Response System (GISRS)" (PDF). who.int. Retrieved 25 May 2020.
  9. ↑ Hay, Alan J; McCauley, John W (2018). "The WHO Global Influenza Surveillance and Response System (GISRS)-A Future Perspective". Influenza and Other Respiratory Viruses. 12 (5): 551–557. doi:10.1111/irv.12565. PMC   6086842 . PMID   29722140. CC BY icon-80x15.png  This article incorporates text available under the CC BY 4.0 license.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.